Chakma Justin sold SPRY
November 12, 2025 · Form 4 insider transaction
Chakma Justin sold 136,380 shares of ARS Pharmaceuticals, Inc. at $8.86 per share, a transaction worth $1.21M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
136,380
Price
$8.86
Total value
$1.21M
InsiderChakma Justin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $8.8634, and the range of prices was between $8.62 and $9.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.